New hope for brain tumor patients: targeted radiation trial launches
Disease control
Recruiting now
This study tests a drug called [177Lu]Lu-DOTATATE, which delivers radiation directly to meningioma tumor cells. It is for adults with progressive grade 1-3 meningioma that has worsened despite prior treatment. The goal is to see if this drug can slow tumor growth and improve surv…
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC